Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 165 $ 186
Accounts receivable, net 16,871 15,405
Inventories 4,821 3,939
Other current assets 2,922 2,535
Total current assets 24,779 22,065
Medical equipment for sale or rental 2,790 1,742
Medical equipment in rental service, net of accumulated depreciation 39,450 39,871
Property & equipment, net of accumulated depreciation 4,385 4,523
Goodwill 3,710 3,710
Intangible assets, net 8,436 10,930
Operating lease right of use assets 4,168 4,241
Deferred income taxes 9,625 10,033
Derivative financial instruments 1,965 355
Other assets 80 116
Total assets 99,388 97,586
Current liabilities:    
Accounts payable 8,341 7,862
Current portion of long-term debt 0 349
Other current liabilities 6,126 4,685
Total current liabilities 14,467 12,896
Long-term debt, net of current portion 33,157 32,748
Operating lease liabilities, net of current portion 3,761 3,670
Total liabilities 51,385 49,314
Stockholders’ equity:    
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued 0 0
Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,781,977 shares issued and outstanding as of December 31, 2022 and 20,699,546 shares issued and outstanding as of December 31, 2021 2 2
Additional paid-in capital 105,856 101,905
Accumulated other comprehensive income 1,489 268
Retained deficit (59,344) (53,903)
Total stockholders’ equity 48,003 48,272
Total liabilities and stockholders’ equity $ 99,388 $ 97,586